These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 18777577)
21. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. Wang J; Wang BM; Schwendeman SP J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744 [TBL] [Abstract][Full Text] [Related]
22. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. Oh JE; Nam YS; Lee KH; Park TG J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414 [TBL] [Abstract][Full Text] [Related]
23. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
24. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry. Passerini N; Craig DQ J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709 [TBL] [Abstract][Full Text] [Related]
26. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair. Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361 [TBL] [Abstract][Full Text] [Related]
27. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation. Yang Z; Birkenhauer P; Julmy F; Chickering D; Ranieri JP; Merkle HP; Lüscher TF; Gander B J Control Release; 1999 Aug; 60(2-3):269-77. PubMed ID: 10425332 [TBL] [Abstract][Full Text] [Related]
28. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. Jiang G; Woo BH; Kang F; Singh J; DeLuca PP J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925 [TBL] [Abstract][Full Text] [Related]
29. Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates. Garcia JT; Fariña JB; Munguía O; Llabrés M J Microencapsul; 1999; 16(1):83-94. PubMed ID: 9972505 [TBL] [Abstract][Full Text] [Related]
30. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering. Boukari Y; Qutachi O; Scurr DJ; Morris AP; Doughty SW; Billa N J Biomater Sci Polym Ed; 2017 Nov; 28(16):1966-1983. PubMed ID: 28777694 [TBL] [Abstract][Full Text] [Related]
31. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. Chung TW; Tsai YL; Hsieh JH; Tsai WJ J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974 [TBL] [Abstract][Full Text] [Related]
32. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites. Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956 [TBL] [Abstract][Full Text] [Related]
33. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. Wang FJ; Wang CH J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566 [TBL] [Abstract][Full Text] [Related]
34. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277 [TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy. Lin Y; Li Y; Ooi CP J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166 [TBL] [Abstract][Full Text] [Related]
36. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis. Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425 [TBL] [Abstract][Full Text] [Related]
37. An experimental design approach to the preparation of pegylated polylactide-co-glicolide gentamicin loaded microparticles for local antibiotic delivery. Dorati R; DeTrizio A; Genta I; Grisoli P; Merelli A; Tomasi C; Conti B Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():909-17. PubMed ID: 26478386 [TBL] [Abstract][Full Text] [Related]
38. Bioactive inorganic-materials/alginate composite microspheres with controllable drug-delivery ability. Wu C; Zhu Y; Chang J; Zhang Y; Xiao Y J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):32-43. PubMed ID: 20225253 [TBL] [Abstract][Full Text] [Related]
39. PLGA/mesoporous silica hybrid structure for controlled drug release. Xue JM; Shi M J Control Release; 2004 Aug; 98(2):209-17. PubMed ID: 15262413 [TBL] [Abstract][Full Text] [Related]
40. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. Ertl B; Platzer P; Wirth M; Gabor F J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]